Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure - PubMed (original) (raw)

Comment

Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure

Vikash P Chauhan et al. Cancer Cell. 2014.

No abstract available

PubMed Disclaimer

Comment in

• Response to Chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning.
  DelGiorno KE, Carlson MA, Osgood R, Provenzano PP, Brockenbough JS, Thompson CB, Shepard HM, Frost GI, Potter JD, Hingorani SR. DelGiorno KE, et al. Cancer Cell. 2014 Jul 14;26(1):16-7. doi: 10.1016/j.ccr.2014.06.004. Cancer Cell. 2014. PMID: 25026210 Free PMC article. No abstract available.

Comment on

• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
  Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Provenzano PP, et al. Cancer Cell. 2012 Mar 20;21(3):418-29. doi: 10.1016/j.ccr.2012.01.007. Cancer Cell. 2012. PMID: 22439937 Free PMC article.

Similar articles

• Response to Chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning.
  DelGiorno KE, Carlson MA, Osgood R, Provenzano PP, Brockenbough JS, Thompson CB, Shepard HM, Frost GI, Potter JD, Hingorani SR. DelGiorno KE, et al. Cancer Cell. 2014 Jul 14;26(1):16-7. doi: 10.1016/j.ccr.2014.06.004. Cancer Cell. 2014. PMID: 25026210 Free PMC article. No abstract available.
• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
  Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Provenzano PP, et al. Cancer Cell. 2012 Mar 20;21(3):418-29. doi: 10.1016/j.ccr.2012.01.007. Cancer Cell. 2012. PMID: 22439937 Free PMC article.
• Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.
  Jacobetz MA, Chan DS, Neesse A, Bapiro TE, Cook N, Frese KK, Feig C, Nakagawa T, Caldwell ME, Zecchini HI, Lolkema MP, Jiang P, Kultti A, Thompson CB, Maneval DC, Jodrell DI, Frost GI, Shepard HM, Skepper JN, Tuveson DA. Jacobetz MA, et al. Gut. 2013 Jan;62(1):112-20. doi: 10.1136/gutjnl-2012-302529. Epub 2012 Mar 30. Gut. 2013. PMID: 22466618 Free PMC article.
• Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.
  Whatcott CJ, Han H, Von Hoff DD. Whatcott CJ, et al. Cancer J. 2015 Jul-Aug;21(4):299-306. doi: 10.1097/PPO.0000000000000140. Cancer J. 2015. PMID: 26222082 Free PMC article. Review.
• Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.
  Zhen DB, Coveler A, Zanon S, Reni M, Chiorean EG. Zhen DB, et al. Semin Oncol. 2018 Jun;45(3):107-115. doi: 10.1053/j.seminoncol.2018.05.004. Epub 2018 Jun 5. Semin Oncol. 2018. PMID: 30391013 Review.

Cited by

• Development of Sentinel LN Imaging with a Combination of HAase Based on a Comprehensive Analysis of the Intra-lymphatic Kinetics of LPs.
  Gomi M, Sakurai Y, Okada T, Miura N, Tanaka H, Akita H. Gomi M, et al. Mol Ther. 2021 Jan 6;29(1):225-235. doi: 10.1016/j.ymthe.2020.09.014. Epub 2020 Sep 6. Mol Ther. 2021. PMID: 32966771 Free PMC article.
• Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer.
  Zhang Z, Zhang H, Liu T, Chen T, Wang D, Tang D. Zhang Z, et al. Front Cell Dev Biol. 2021 Dec 20;9:783617. doi: 10.3389/fcell.2021.783617. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34988078 Free PMC article. Review.
• Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
  Martin JD, Cabral H, Stylianopoulos T, Jain RK. Martin JD, et al. Nat Rev Clin Oncol. 2020 Apr;17(4):251-266. doi: 10.1038/s41571-019-0308-z. Epub 2020 Feb 7. Nat Rev Clin Oncol. 2020. PMID: 32034288 Free PMC article. Review.
• Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1.
  Chang J, Lo ZHY, Alenizi S, Kovacevic Z. Chang J, et al. Cancers (Basel). 2023 May 16;15(10):2779. doi: 10.3390/cancers15102779. Cancers (Basel). 2023. PMID: 37345116 Free PMC article. Review.
• Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer.
  Nieskoski MD, Marra K, Gunn JR, Hoopes PJ, Doyley MM, Hasan T, Trembly BS, Pogue BW. Nieskoski MD, et al. Sci Rep. 2017 Aug 30;7(1):10093. doi: 10.1038/s41598-017-10671-w. Sci Rep. 2017. PMID: 28855644 Free PMC article.

References

1. 1. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Research. 1992;52:5110–5114. - PubMed
2. 1. Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, Stylianopoulos T, Mousa A, Han X, Adstamongkonkul P, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumor blood vessels. Nature Communications. 2013;4:2516. - PMC - PubMed
3. 1. Ozerdem U, Hargens AR. A simple method for measuring interstitial fluid pressure in cancer tissues. Microvascular Research. 2005;70:116–120. - PMC - PubMed
4. 1. Provenzano Paolo P, Cuevas C, Chang Amy E, Goel Vikas K, Von Hoff Daniel D, Hingorani Sunil R. Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2012;21:418–429. - PMC - PubMed
5. 1. Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, Bardeesy N, Smith BL, Ferrone CR, Hornicek FJ, Boucher Y, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:15101–15108. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• T32 CA073479/CA/NCI NIH HHS/United States
• P30 CA016672/CA/NCI NIH HHS/United States
• R01 CA126642/CA/NCI NIH HHS/United States
• R01 CA098706/CA/NCI NIH HHS/United States
• R01 CA085140/CA/NCI NIH HHS/United States
• R24 CA085140/CA/NCI NIH HHS/United States
• R01 CA115767/CA/NCI NIH HHS/United States
• R01 HL106584/HL/NHLBI NIH HHS/United States
• P41 EB015903/EB/NIBIB NIH HHS/United States
• P01 CA080124/CA/NCI NIH HHS/United States
• DP2 OD008780/OD/NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)